These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38828448)

  • 1. Editorial: Anti-inflammatory drug development focusing on immune mediated diseases.
    Oliveira-Costa JF; Prasad A
    Front Pharmacol; 2024; 15():1413141. PubMed ID: 38828448
    [No Abstract]   [Full Text] [Related]  

  • 2. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.
    Deshpande RR; Tiwari AP; Nyayanit N; Modak M
    Eur J Pharmacol; 2020 Nov; 886():173430. PubMed ID: 32758569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of
    Devaprasad A; Radstake TRDJ; Pandit A
    Front Immunol; 2021; 12():669400. PubMed ID: 34108969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics.
    Singhal S; Maheshwari P; Krishnamurthy PT; Patil VM
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2726-2756. PubMed ID: 35301945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
    Hudson ML; Samudrala R
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Drugs to Treat Heart and Brain Illness.
    Cantrell MS; Soto-Avellaneda A; Wall JD; Ajeti AD; Morrison BE; Warner LR; McDougal OM
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment.
    Jain H; Bhat AR; Dalvi H; Godugu C; Singh SB; Srivastava S
    Curr Res Pharmacol Drug Discov; 2021; 2():100041. PubMed ID: 34909670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and dynamics approach to
    Halder D; Das S; Joseph A; Jeyaprakash RS
    J Biomol Struct Dyn; 2023 May; 41(8):3462-3475. PubMed ID: 35285757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
    Nakata M; Tang W
    Drug Discov Ther; 2008 Oct; 2(5):262-3. PubMed ID: 22504718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: inflammatory responses, structure-based drug design and potential therapeutics.
    Tripathi N; Tripathi N; Goshisht MK
    Mol Divers; 2022 Feb; 26(1):629-645. PubMed ID: 33400086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.
    Patrick MT; Raja K; Miller K; Sotzen J; Gudjonsson JE; Elder JT; Tsoi LC
    J Invest Dermatol; 2019 Mar; 139(3):683-691. PubMed ID: 30342048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment.
    Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A
    Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Drug Repurposing for Anti-Inflammatory Therapy: Virtual Search for Dual Inhibitors of Caspase-1 and TNF-Alpha.
    Speck-Planche A; Kleandrova VV; Scotti MT
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis.
    Prasannanjaneyulu V; Nene S; Jain H; Nooreen R; Otavi S; Chitlangya P; Srivastava S
    Cytokine Growth Factor Rev; 2022 Jun; 65():12-26. PubMed ID: 35550114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques.
    Aalikhani M; Alikhani M; Shamsabadi F; Oladnabi M; Bazi Z
    Biochem Biophys Res Commun; 2021 Oct; 572():138-144. PubMed ID: 34364293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing potential of 1st generation H
    Schafer A; Cheng H; Xiong R; Soloveva V; Retterer C; Mo F; Bavari S; Thatcher G; Rong L
    Antiviral Res; 2018 Sep; 157():47-56. PubMed ID: 29981374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: an In Silico Repurposing Approach.
    Ibrahim A; Ipinloju N; Atasie NH; Babalola RM; Muhammad SA; Oyeneyin OE
    Appl Biochem Biotechnol; 2023 Oct; 195(10):5980-6002. PubMed ID: 36735144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing.
    de Anda-Jáuregui G; Guo K; McGregor BA; Hur J
    Front Physiol; 2018; 9():151. PubMed ID: 29545755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators.
    Hassan AHE; Yoo SY; Lee KW; Yoon YM; Ryu HW; Jeong Y; Shin JS; Kang SY; Kim SY; Lee HH; Park BY; Lee KT; Lee YS
    Eur J Med Chem; 2019 Oct; 180():253-267. PubMed ID: 31310917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
    Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
    Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.